Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
ALI HEALTH
00241
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -0.61%10.44B | 7.42%21.31B | 6.26%10.5B | -1.15%19.84B | -2.73%9.88B | 17.21%20.07B | 30.72%10.16B | 33.52%17.13B | 39.71%7.77B | -0.76%12.83B |
| Operating income | -0.61%10.44B | 7.42%21.31B | 6.26%10.5B | -1.15%19.84B | -2.73%9.88B | 17.21%20.07B | 30.72%10.16B | 33.52%17.13B | 39.71%7.77B | -0.76%12.83B |
| Cost of sales | -0.79%-9.63B | -6.83%-19.42B | -5.74%-9.55B | 1.53%-18.18B | 2.15%-9.03B | -22.91%-18.46B | -36.53%-9.23B | -36.52%-15.02B | -40.19%-6.76B | 1.49%-11B |
| Operating expenses | -0.79%-9.63B | -6.83%-19.42B | -5.74%-9.55B | 1.53%-18.18B | 2.15%-9.03B | -22.91%-18.46B | -36.53%-9.23B | -36.52%-15.02B | -40.19%-6.76B | 1.49%-11B |
| Gross profit | -14.69%810.48M | 13.84%1.89B | 11.69%950.06M | 3.19%1.66B | -8.54%850.65M | -23.43%1.61B | -8.08%930.06M | 15.42%2.11B | 36.60%1.01B | 3.92%1.82B |
| Special items of operating profit | -5.19%247.75M | -35.34%400.35M | -69.57%261.31M | -6.87%619.19M | 39.44%858.6M | 377.81%664.84M | 783.13%615.74M | -322.24%-239.32M | 68.72%69.72M | 226.19%107.68M |
| Operating profit | -12.64%1.06B | 0.50%2.29B | -29.13%1.21B | 0.25%2.28B | 10.57%1.71B | 22.01%2.28B | 42.93%1.55B | -3.40%1.87B | 38.30%1.08B | 15.68%1.93B |
| Financing cost | 7.87%-331.14M | 5.36%-728.6M | 12.23%-359.42M | -2.27%-769.84M | -10.16%-409.5M | -27.82%-752.76M | -58.45%-371.73M | -38.18%-588.92M | -21.65%-234.6M | -6.90%-426.2M |
| Share of profits of associates | 90.88%211.78M | -3.29%353.64M | 77.77%110.95M | 248.14%365.66M | -45.69%62.41M | -156.64%-246.84M | -38.43%114.91M | 20.16%435.81M | 34.30%186.64M | 0.94%362.69M |
| Share of profit from joint venture company | 19.70%166.34M | -10.07%285.57M | 23.73%138.97M | 3.76%317.53M | -29.17%112.32M | -29.07%306.03M | -14.76%158.57M | 29.11%431.44M | 14.80%186.02M | -12.80%334.17M |
| Earning before tax | 0.30%1.11B | 0.40%2.21B | -25.27%1.1B | 38.69%2.2B | 1.86%1.47B | -26.16%1.58B | 18.69%1.45B | -2.63%2.14B | 37.00%1.22B | 9.37%2.2B |
| Tax | -4.39%-266.89M | -6.11%-408.65M | -5.02%-255.68M | -0.64%-385.11M | 12.38%-243.46M | 38.05%-382.67M | 12.03%-277.87M | -11.31%-617.66M | -37.96%-315.88M | -10.65%-554.89M |
| After-tax profit from continuing operations | -0.93%838.32M | -0.82%1.8B | -31.26%846.19M | 50.81%1.81B | 5.24%1.23B | -21.35%1.2B | 29.43%1.17B | -7.33%1.53B | 36.67%903.71M | 8.94%1.65B |
| Earning after tax | -0.93%838.32M | -0.82%1.8B | -31.26%846.19M | 50.81%1.81B | 5.24%1.23B | -21.35%1.2B | 29.43%1.17B | -7.33%1.53B | 36.67%903.71M | 8.94%1.65B |
| Minority profit | -22.75%79.93M | -19.57%190.38M | -10.49%103.47M | 0.22%236.7M | -9.73%115.6M | -13.77%236.18M | 1.99%128.07M | 36.47%273.89M | 56.03%125.57M | -1.69%200.7M |
| Profit attributable to shareholders | 2.11%758.39M | 2.00%1.61B | -33.41%742.71M | 63.20%1.57B | 7.09%1.12B | -23.01%964.86M | 33.86%1.04B | -13.40%1.25B | 33.99%778.13M | 10.60%1.45B |
| Dividend | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 3.42%445.34M |
| Dividend per share | ---- | 18.75%0.19 | ---- | 6.67%0.16 | ---- | 0.00%0.15 | ---- | --0.15 | ---- | ---- |
| Basic earnings per share | -1.36%0.218 | -1.26%0.471 | -35.62%0.221 | 58.10%0.477 | 3.90%0.3433 | -27.35%0.3017 | 26.06%0.3304 | -16.20%0.4153 | 29.56%0.2621 | 7.60%0.4956 |
| Diluted earnings per share | 7.77%0.208 | 0.47%0.427 | -36.09%0.193 | 195.55%0.425 | 89.58%0.302 | -65.37%0.1438 | 0.1593 | 0.4153 | ||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.